CLINICAL TRIALS BY STATE

Clinical Trials in Oregon

12+ recruiting studies in Oregon, updated in real time and displayed in plain English.

BROWSE BY CONDITION IN OREGON

Bladder CancerBrain Tumor / GliomaBreast CancerCervical CancerColorectal CancerEndometrial / Uterine CancerHead & Neck CancerKidney / Renal Cell CarcinomaLeukemia (AML)Leukemia (CLL)Liver / Hepatocellular CarcinomaLung Cancer (NSCLC)Lung Cancer (SCLC)Lymphoma (Non-Hodgkin)MelanomaMultiple MyelomaOvarian CancerPancreatic Cancer

RECRUITING TRIALS IN OREGON

RECRUITINGPhase 1

A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

NCT07553429 · Phoenix, Associated Retina Consultants, Ltd.
RECRUITINGPhase 2

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

NCT07129993 · Fullerton, Research Site
RECRUITINGNA

ELEVATE High-Risk PCI Pivotal Study

NCT07001332 · Phoenix, Banner-University Medical Center
RECRUITINGEARLY/Phase 1

Endometrial Biopsy in Progestin Contraceptive Users

NCT05760144 · Portland, OHSU
RECRUITINGPhase 3

IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

NCT07104032 · Phoenix, Mayo Clinic Cancer Center
RECRUITINGPhase 2

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

NCT07415044 · Phoenix, Valleywise Health Medical Center
RECRUITINGPhase 3

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

NCT06170788 · Phoenix, Mayo Clinic in Arizona - Phoenix ( Site 0147)
RECRUITINGPhase 3

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

NCT06793215 · Anchorage, Alaska Oncology and Hematology
RECRUITINGPhase 1

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

NCT06515613 · Little Rock, University of Arkansas Winthrop P. Rockefeller Cancer Institute
RECRUITING

Clinical Course Of Disease In Participants With FA-CM

NCT06865482 · La Jolla, University of California San Diego
RECRUITINGPhase 2

Epetraborole in Patients With Mycobacterium Abscessus Lung Disease

NCT07301320 · Portland, Oregon Health & Science University
RECRUITINGPhase 2

Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC

NCT05491525 · Little Rock, Arkansas Childrens Hospital

COMMON QUESTIONS

How many clinical trials are available in Oregon?

There are currently 12+ recruiting clinical trials in Oregon listed on ClinicalTrials.gov. Clinicals AI makes these easier to browse with plain-language summaries and condition filters.

How do I join a clinical trial in Oregon?

Browse the listings above, review eligibility criteria, and submit a contact request. A study coordinator will follow up to discuss your eligibility and next steps.

Are clinical trials in Oregon free?

Most trials cover the investigational treatment and study-related visits at no cost. Some also offer compensation for time and travel. Confirm cost details with each trial coordinator.

What conditions have trials in Oregon?

Oregon hosts trials across cancer, cardiovascular disease, diabetes, neurological conditions, mental health, autoimmune disease, and rare conditions. Browse by condition using the links above.

OTHER STATES

CaliforniaNew YorkTexasFloridaPennsylvaniaOhioIllinoisMassachusettsMichiganWashington